Jul 29, 2026 07:05AM
Jul 29, 2026 07:05AM
Jul 29, 2026 07:00AM
Jul 23, 2026 07:11AM
Jul 14, 2026 09:16AM
Jul 14, 2026 09:16AM
Jul 13, 2026 07:01AM Ionis starts Phase 1-2 trial of ION337 for Dravet syndrome
Jul 13, 2026 07:00AM
Jul 6, 2026 07:00AM
Jul 6, 2026 07:00AM
Jun 25, 2026 07:12AM
Jun 25, 2026 06:48AM
Jun 25, 2026 03:33AM
Jun 25, 2026 02:59AM Ionis licenses zilganersen to Recordati for ex-U.S. markets
Jun 25, 2026 02:59AM
Jun 24, 2026 02:39PM
Jun 24, 2026 02:37PM
Jun 4, 2026 07:00AM
Jun 1, 2026 06:57AM
May 28, 2026 04:45AM
May 14, 2026 07:05AM Biogen advances IONIS alzheimer's drug after phase 2 study shows cognitive benefit
May 14, 2026 07:05AM
Apr 29, 2026 07:00AM
Apr 28, 2026 02:06AM
Apr 28, 2026 02:06AM
Apr 21, 2026 07:03AM
Apr 21, 2026 07:00AM
Mar 30, 2026 07:30AM FDA approves high dose SPINRAZA for spinal muscular atrophy
Mar 30, 2026 07:30AM
Mar 23, 2026 07:00AM
Mar 23, 2026 07:00AM
Mar 9, 2026 07:00AM
Mar 9, 2026 07:00AM
Mar 5, 2026 07:30AM
Feb 26, 2026 07:00AM FDA accepts Ionis olezarsen application for priority review
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 25, 2026 01:20PM
Feb 25, 2026 07:00AM
Feb 4, 2026 07:30AM
Feb 4, 2026 07:30AM
Jan 21, 2026 07:00AM DAWNZERA gets European Commission approval for hereditary angioedema
Jan 21, 2026 07:00AM
Jan 12, 2026 11:06AM
Jan 12, 2026 11:05AM
Jan 12, 2026 07:00AM
Jan 7, 2026 02:15AM
Jan 7, 2026 02:15AM
Dec 2, 2025 07:00AM Ionis receives FDA breakthrough therapy designation for Alexander disease drug
Dec 2, 2025 07:00AM

328,206 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All